A European business lobby group urged China to take steps not to prioritise low prices over product safety in the country's centralised drug procurement programme.
Bulk drug imports from China increased from 62 per cent to 75 per cent in the past nine years and India continues to depend on Chinese shipments despite commissioning of various domestic manufacturing ...
SF Group revealed that it had held a tripartite meeting yesterday (11th) in Hong Kong with Sinopec Hong Kong and China Environmental ... of intent on the purchase of SAF in bulk.